Cargando…

Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice

Patients with Systemic Lupus Erythematosus (SLE) suffer from a chronic inflammatory autoimmune disease that results from the body's immune system targeting healthy tissues which causes damage to various organ systems. Patients with lupus are still in need of effective therapies to treat this co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soto, Maira, Delatorre, Nicole, Hurst, Chelsie, Rodgers, Kathleen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390909/ https://www.ncbi.nlm.nih.gov/pubmed/32793221 http://dx.doi.org/10.3389/fimmu.2020.01572

Ejemplares similares

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
por: Gulinello, Maria, et al.
Publicado: (2011)

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice
por: Stock, Ariel D., et al.
Publicado: (2015)

Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice
Publicado: (1981)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015)

Prolactin Levels Correlate with Abnormal B Cell Maturation in MRL and MRL/lpr Mouse Models of Systemic Lupus Erythematosus-Like Disease
por: Legorreta-Haquet, Maria Victoria, et al.
Publicado: (2013)

Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr Mice
por: Zhu, Jiali, et al.
Publicado: (2014)

Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
por: Wang, Ruxuan, et al.
Publicado: (2022)

Reduced receptor editing in lupus-prone MRL/lpr mice
por: Lamoureux, Jennifer L., et al.
Publicado: (2007)

ALW peptide ameliorates lupus nephritis in MRL/lpr mice
por: Wang, Huixia, et al.
Publicado: (2019)

Improving the Innate Immune Response in Diabetes by Modifying the Renin Angiotensin System
por: Soto, Maira, et al.
Publicado: (2019)

Anti-RNA polymerase I antibodies in sera of MRL lpr/lpr and MRL +/+ autoimmune mice. Correlation of antibody production with delayed onset of lupus-like disease in MRL +/+ mice
Publicado: (1985)

Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus
por: Cai, Zhe, et al.
Publicado: (2016)

Murine lupus is neutrophil elastase-independent in the MRL.Fas(lpr) model
por: Gordon, Rachael A., et al.
Publicado: (2020)

Renin Angiotensin system-modifying therapies are associated with improved pulmonary health
por: Soto, Maira, et al.
Publicado: (2017)

The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus
por: Liu, Yuan, et al.
Publicado: (2015)

Self-Reactivity and the Expression of Memory Markers Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr Mice
por: Smyth, Lesley, et al.
Publicado: (1992)

The Protective Effects of Ultraviolet A1 Irradiation on Spontaneous Lupus Erythematosus-Like Skin Lesions in MRL/lpr Mice
por: Mikita, Naoya, et al.
Publicado: (2009)

Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
por: Weinberg, J B
Publicado: (1998)

Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
Publicado: (1991)

Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
por: Yi, Xiaoqing, et al.
Publicado: (2023)

Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice
por: Nowling, Tamara K., et al.
Publicado: (2020)

Immunomodulatory effects of atorvastatin on MRL/lpr mice
por: Sun, Jing, et al.
Publicado: (2022)

Defective maintenance of T cell tolerance to a superantigen in MRL- lpr/lpr mice
Publicado: (1992)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019)

Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL/lpr mice
por: Cabana-Puig, Xavier, et al.
Publicado: (2022)

Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL/lpr mice
por: Zhang, Xin, et al.
Publicado: (2023)

The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice
Publicado: (1988)

A Tissue-Tended Mycophenolate-Modified Nanoparticle Alleviates Systemic Lupus Erythematosus in MRL/Lpr Mouse Model Mainly by Promoting Local M2-Like Macrophagocytes Polarization
por: Jiang, Biling, et al.
Publicado: (2022)

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus
por: Doerner, Jessica, et al.
Publicado: (2015)

Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model
por: Liao, Xiaofeng, et al.
Publicado: (2015)

Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
por: Keil, Andreas, et al.
Publicado: (2016)

Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice
por: Liu, Jingqun, et al.
Publicado: (2022)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

Complement Properdin Determines Disease Activity in MRL/lpr Mice
por: Alaridhee, Hasanain, et al.
Publicado: (2020)

Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice
Publicado: (1983)

MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis
por: Huang, Xinglan, et al.
Publicado: (2022)

Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice
por: Nakatani, Kimihiko, et al.
Publicado: (2013)

The Therapeutic Effects of the Chinese Herbal Medicine, Lang Chuang Fang Granule, on Lupus-Prone MRL/lpr Mice
por: Huang, Kai-Peng, et al.
Publicado: (2016)

MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice
por: Xia, Yuan, et al.
Publicado: (2018)

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
por: Watanabe, Haruki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1l0hqnpkq5l3lft9bobtdhl5tl